braun getty

2013 Preview: Why Ryan Braun, Alex Rodriguez and other big stars could face suspension this season

70 Comments

As we approach Opening Day, HarballTalk will be spending the next few days previewing all 30 teams, all six division races and looking ahead at the major issues and storylines which will impact the 2013 season. This morning we look at the Biogenesis scandal, which could lead to the suspension of several high-profile players.

Some of baseball’s biggest stars including Ryan Braun, Alex Rodriguez, Nelson Cruz, Gio Gonzalez, Yasmani Grandal, Bartolo Colon and many, many more enter the 2013 season under a cloud. Or a threat, if you will.  The threat of suspension for their association with a now-closed Miami clinic called Biogenesis, which is alleged to have supplied these players and as many as 90 more with testosterone, human growth hormone and other performance enhancing drugs which violate baseball’s rules against performance enhancing drugs. It is unknown if those suspensions will come. It is unknown when. But all teams with a player named in the documents of the Biogenesis clinic face uncertainty as Opening Day approaches.

The Biogenesis news broke in late January, when it was reported by multiple outlets that Major League Baseball was investigating the clinic and its operator, Anthony Bosch, under the suspicion that the clinic represented “ground zero” for performance enhancing drugs in Florida, where a disproportionate number of major leaguers grew up, played amateur and college baseball or where they currently make their offseason homes. On January 29, the Miami New Times obtained and published a large portion of the Biogenesis clinic’s records which contained the names of several major leaguers accompanied in many cases by notations which suggested that the players were given performance enhancing drugs. The documents were not conclusive of any player’s use and, in some cases — like with Nationals pitcher Gio Gonzalez — no connection could be found between the player and any substances which are banned by Major League Baseball.

source: APImmediately after the Miami New Times report came out all of the players involved either denied any involvement with Biogenesis whatsoever or denied that they obtained banned substances.  For example, Gonzalez claims that his father was a patient of Anthony Bosch’s. Ryan Braun claims that his attorneys used Bosch as a consultant in his successful 2012 appeal of his PED suspension. Despite the denials, the report and the documents set off a media firestorm which caused Major League Baseball to step up its investigation of the players named therein.

The biggest problem: Major League Baseball doesn’t actually have the Biogenesis documents. The Miami New Times and other media outlets which have seen all or part of them are unwilling to share them with the league and, at present, Anthony Bosch is nowhere to be found.  Last Friday Major League Baseball sued Biogenesis in an effort to obtain the documents, but it is not at all clear that they have any viable legal claims against the clinic. More significantly, many doubt that the original documents still exist at all.

What is clear is that Major League Baseball is stopping at nothing to investigate the matter with a clear eye towards suspending the players named in the clinic’s records if at all possible.  MLB is reported to be particularly interested in suspending 2011 NL MVP Braun, who they see as having evaded justice in prevailing on his appeal last year and Rodriguez who many in baseball believe lied to MLB investigators in 2009 when he admitted to past, but not present drug use.

MORE: The Rise and Fall of Alex Rodriguez

source: APCan Major League Baseball suspend these players without a positive drug test? Yes, it can. Pursuant to the Joint Drug Agreement which governs these matters, baseball can suspend players for “just cause” if there is non-clinical evidence suggesting that they have used performance enhancing drugs. Most believe that conclusive documentary evidence of past use, as may appear in the Biogenesis records, would provide such grounds. Baseball’s inability to obtain these records, however, is preventing almost all action at present. So far, all baseball has been able to do is to suspend one minor leaguer  — who happens to have been a college teammate and who is still a close friend of Braun’s — who was implicated based on the league’s belief that he was not cooperative when questioned. Major league players have not yet been questioned, but they almost certainly will be.  They will have greater legal and union protections from discipline than their minor league counterparts, however.

That’s where we are as the season dawns. Several players, including two former MVPs, in the crosshairs of a Major League Baseball investigation, the outcome of which and endpoint of is uncertain. At literally any time between today and, well, forever, baseball could suspend Braun, Rodriguez, Gonzalez, Cruz or any of players named in the Biogenesis documents for 50 games.

To put that in context, the most big leaguers Major League Baseball has ever suspended in a season for performance enhancing drugs is six, which occurred last year.  In most years it’s two or three.  Now dozens upon dozens of players may face a 50-game suspension for a first offense of the Joint Drug Agreement, with some facing 100-game suspensions for a second offense. Suspensions of this magnitude could conceivably tip the pennant races. And for that reason, even if you don’t care a lick about performance enhancing drugs in baseball, the Biogenesis matter is worth watching.

MORE: Team-by-team previews for 2013

Drew Smyly brings youth and experience to Mariners rotation

170224-smyly
Getty Images
Leave a comment

PEORIA, Ariz. (AP) Trades don’t surprise Drew Smyly anymore.

At age 27, the Seattle Mariners left-hander has been dealt twice. The first swap sent him from the team that drafted and developed Smyly, the Detroit Tigers, to the Tampa Bay Rays in midseason 2014. That trade landed star pitcher David Price in Detroit.

“I was surprised by that one,” Smyly said.

The most recent trade involving him came in January, when the Rays shipped Smyly to Seattle for three prospects in one of many moves by Mariners general manager Jerry Dipoto. Smyly immediately joined the Mariners’ projected starting rotation, and is having fun getting to know his new teammates at spring training by way of manager Scott Servais’ clubhouse icebreakers.

Servais thinks Smyly is a solid fit as a still young yet experienced pitcher.

“One, being where he’s at in his career age-wise and service time, he’s kind of at the point where, put him in the right environment … very good defensive outfield, he’s a fly ball guy, maybe he does step up and take the next step,” Servais said. “Getting out of the American League East certainly should help him, but there’s no guarantees. Our division’s pretty tough.”

Servais suggested that another Arkansas native, ex-big leaguer Cliff Lee, might have helped sell Seattle on Smyly. Lee is a former Mariner and the two share an agent.

Smyly went 7-12 in a career-high 30 starts last season in Tampa, but won five games from July 30 to the end of the season after starting out 2-11. From May 21 to July 18, he lost seven straight starts.

“Pitching’s tough, you know,” Smyly said. “To manipulate the ball, to make it do different things, to put it in the strike zone with hitters that know what they’re doing. … I just had a rough stretch but I show up at the field every day, play catch and work on my craft and you know, that’s going to turn around one day.”

The 32 home runs Smyly surrendered in 2016 figure to be reduced in Seattle’s pitcher-friendly Safeco Field.

“It can only help,” he said. “But it’s still going to be up to me to execute pitches and pitch well.”

Smyly is set to join the U.S. World Baseball Classic team shortly. Before that, he’ll make his first spring training start in the middle of next week.

“It’s an honor to be able to put your country on your chest and play with some of the guys on that team,” he said. “I’m looking forward to it big time.”

NOTES: Servais plans to roll out what figures to be Seattle’s opening day lineup in the spring training opener Saturday against San Diego. It’s OF Jarrod Dyson, SS Jean Segura, 2B Robinson Cano, DH Nelson Cruz, 3B Kyle Seager, OF Mitch Haniger, 1B Dan Vogelbach, C Mike Zunino and OF Leonys Martin. … Servais said Cano and Cruz will play a little more than is typical for early spring games, as the two will depart for the World Baseball Classic in early March. … LHP Ariel Miranda will start Saturday, then RHP Chris Heston Sunday, RHP Yovani Gallardo on Monday and ace Felix Hernandez on Tuesday.

Mitt Romney’s sons are trying to buy a stake in the Yankees

TAMPA, FL - AUGUST 30:  Tagg Romney son of Republican presidential candidate, former Massachusetts Gov. Mitt Romney gives an interview during the final day of the Republican National Convention at the Tampa Bay Times Forum on August 30, 2012 in Tampa, Florida. Former Massachusetts Gov. Mitt Romney was nominated as the Republican presidential candidate during the RNC which will conclude today.  (Photo by Chip Somodevilla/Getty Images)
Getty Images
21 Comments

Mitt Romney built his professional life in Massachusetts and was once the governor of the state. As such, it is not surprising that he has long identified as a Red Sox fan. So this has to be troubling to him from a fan’s perspective. From Jon Heyman:

The Romney family is bidding to buy a small stake in the Yankees months after their try for the Marlins stalled. If the deal goes through, it is expected to be $25 million to $30 million per percentage point and thought to be interested in one or two percentage points. The Yankees are valued around $3 billion or more.

The effort is being led by Mitt’s son Tagg, one of his brothers and their business partners. Mitt’s spokesman tells Jon Heyman that he has nothing to do with it personally. Tagg Romney is reported to have been planning a bid for controlling interest in the Marlins, but that has fallen through.

I find this interesting insofar as the M.O. for the Steinbrenners has, for years, been to buy out minority shareholders in the Yankees, not seek more. Indeed, when George Steinbrenner bought the Yankees back in 1973 he held just a bare controlling interest and there were a ton of silent partners, most of which were back in Ohio and knew Steinbrenner from his shipping business. I’ve personally gotten to know some of them over the years as there are a handful of them in Columbus and I crossed paths with them in my legal career. They have almost all been bought out in the past couple of decades. They still get season tickets and World Series rings and stuff. You can tell them by their personalized Yankees plates and the fact that, within the first ten minutes of meeting them, they will tell you that they once owned a piece of the Yankees but got pushed out.

In light of all of that it’s interesting that the Steinbrenners are once again accepting bids for small stakes in the team. Especially from someone whose interest in controlling the Marlins suggests that they do not consider it to be a mere vanity investment. Makes me wonder what the Steinbrenners’ long term plans are.